Trial Profile
An Open-lable, Prospective Study to Evaluate the Pharmacokinetics and Pleural Fluid Penetration of Moxifloxacin in Patients with Pleural Effusion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Pleural effusion
- Focus Pharmacokinetics
- 02 Dec 2015 New trial record